Benzinga

España
Italia
대한민국
日本
Français
Benzinga Edge
Benzinga Research
Benzinga Pro

  • Get Benzinga Pro
  • Data & APIs
  • Events
  • Premarket
  • Advertise
Contribute
España
Italia
대한민국
日本
Français

Benzinga

  • Premium Services
  • Financial News
    Latest
    Earnings
    Guidance
    Dividends
    M&A
    Buybacks
    Interviews
    Management
    Offerings
    IPOs
    Insider Trades
    Biotech/FDA
    Politics
    Healthcare
    Small-Cap
  • Markets
    Pre-Market
    After Hours
    Movers
    ETFs
    Options
    Cryptocurrency
    Commodities
    Bonds
    Futures
    Mining
    Real Estate
    Volatility
  • Ratings
    Analyst Color
    Downgrades
    Upgrades
    Initiations
    Price Target
  • Investing Ideas
    Trade Ideas
    Long Ideas
    Short Ideas
    Technicals
    Analyst Ratings
    Analyst Color
    Latest Rumors
    Whisper Index
    Stock of the Day
    Best Stocks & ETFs
    Best Penny Stocks
    Best S&P 500 ETFs
    Best Swing Trade Stocks
    Best Blue Chip Stocks
    Best High-Volume Penny Stocks
    Best Small Cap ETFs
    Best Stocks to Day Trade
    Best REITs
  • Money
    Investing
    Cryptocurrency
    Mortgage
    Insurance
    Yield
    Personal Finance
    Forex
    Startup Investing
    Real Estate Investing
    Prop Trading
    Credit Cards
    Stock Brokers
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
Unusual Options Activity Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Screeners
Stock Screener
Top Momentum Stocks
Top Quality Stocks
Top Value Stocks
Top Growth Stocks
Compare Best Stocks
Best Momentum Stocks
Best Quality Stocks
Best Value Stocks
Best Growth Stocks
Connect With Us
facebookinstagramlinkedintwitteryoutubeblueskymastodon
About Benzinga
  • About Us
  • Careers
  • Advertise
  • Contact Us
Market Resources
  • Advanced Stock Screener Tools
  • Options Trading Chain Analysis
  • Comprehensive Earnings Calendar
  • Dividend Investor Calendar and Alerts
  • Economic Calendar and Market Events
  • IPO Calendar and New Listings
  • Market Outlook and Analysis
  • Wall Street Analyst Ratings and Targets
Trading Tools & Education
  • Benzinga Pro Trading Platform
  • Options Trading Strategies and News
  • Stock Market Trading Ideas and Analysis
  • Technical Analysis Charts and Indicators
  • Fundamental Analysis and Valuation
  • Day Trading Guides and Strategies
  • Live Investor Events
  • Pre-market Stock Analysis and News
  • Cryptocurrency Market Analysis and News
Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

  • Terms & Conditions
  • Do Not Sell My Personal Data/Privacy Policy
  • Disclaimer
  • Service Status
  • Sitemap
© 2026 Benzinga | All Rights Reserved
July 25, 2024 11:23 AM 2 min read

BUD On The Rocks? Stock Flirts With Death Cross Ahead Of Q2 Earnings

by Surbhi Jain
Follow

Anheuser-Busch InBev SA/NV (NYSE:BUD) will be reporting its second-quarter earnings on Aug 1. Wall Street expects 87 cents in EPS and $13.6 billion in revenues as the company reports before market hours.

The stock is up 3.73% over the past year, down 6.30% YTD.

Let’s look at what the charts indicate for Anheuser-Busch stock, and how the stock currently maps against Wall Street estimates.

Anheuser-Busch Stock Approaching A Potential Death Cross Ahead Of Q2 Earnings…

Chart created using Benzinga Pro

Anheuser-Busch stock appears to be heading towards a Death Cross, a bearish technical pattern where the 50-day simple moving average (SMA) is poised to cross below the 200-day SMA.

Chart created using Benzinga Pro

This pattern often signals a potential for further downside in the stock. Currently, BUD's stock price of $60.55 is trading below the 50-day SMA of $61.67 and the 200-day SMA of $61.05, reinforcing the bearish outlook.

Chart created using Benzinga Pro

While the 20-day SMA of $60.01 and the MACD indicator at 0.01 provide some bullish signals, the stock’s RSI of 50.08 indicates that it is neither overbought or overbought.

Additionally, the Bollinger Bands’ upper limit at $60.89 indicates potential selling pressure.

As BUD stock approaches this critical technical juncture, investors should be cautious of the anticipated bearish momentum and consider potential risks associated with the death cross.

Read Also: AB InBev’s Plans on Track: Can It Retain Momentum?

Yet Anheuser-Busch Analysts See 15% Upside

Ratings & Consensus Estimates: The consensus analyst rating on Anheuser-Busch stock stands at Overweight currently with a price target of $71.70. Recent analyst ratings from Morgan Stanley, TD Cowen, and Jefferies imply a 15.58% upside for Anheuser-Busch InBev SA/NV, with an average price target of $69.83.

BUD Price Action: Anheuser-Busch stock was trading at $60.42 at the time of publication.

Read Next:

  • Hold My Beer: Breweries Offer THC On Tap In Minnesota, What Investors Need To Know

Photo: Shutterstock

Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

To add Benzinga News as your preferred source on Google, click here.


Posted In:
Analyst ColorTechnicalsTop StoriesTrading IdeasDeath CrossExpert IdeasPro ProjectStories That Matter
BUD Logo
BUDAnheuser-Busch InBev SA/NV
$79.08-0.26%
Overview
BUD Logo
BUDAnheuser-Busch InBev SA/NV
$79.08-0.26%
Overview
Comments
Loading...